FOXL2 and non-small cell lung carcinoma: In the current study, we reported that miR‐133b downregulated FOXL2 by targeting its 3′‐UTR, thereby inhibiting cell proliferation, EMT and metastasis induced by the TGF‐β/Smad signaling pathway in NSCLC.